HealthcareAscendis raised to outperform by Oppenheimer ahead of drug launchBy Helitra.com·September 7, 2024·1 min read Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: SeekingalphaADVERTISEMENT ADVERTISEMENTahead Ascendis drug launch Oppenheimer outperform raised Post navigation Previous storyVor Bio stock rallies post-market on trem-cel study dataNext storyLisata jumps on FDA orphan drug status for liver cancer drug
Fitness · Healthcare8 Trainer-Approved Exercises for Gamers to Prevent Wrist, Neck and Shoulder PainNovember 20, 2026If your plans include an extended trip to Vice City this week, you probably expect your body to be hurting. But whether or…
Fitness · HealthcareSchools Are Banning Caffeine Pouches—Here’s What Parents Should KnowNovember 20, 2026Key Takeaways Caffeine pouches can contain up to 200 mg of caffeine, which can put kids’ health at risk. Some schools are banning…
Fitness · HealthcareAre GLP-1s Entering the Psoriasis Chat?November 20, 2026When you buy through links on our articles, Future and its syndication partners may earn a commission. Inflammation is one of those buzzwords…